The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial

This publication has 14 references indexed in Scilit:

• Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.
  Journal of Clinical Oncology, 1995
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1992
• Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.
  Journal of Clinical Oncology, 1992
• Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.
  Journal of Clinical Oncology, 1991
• Multiple confirmatory trials. How can additional studies be of value?
  Annals of Oncology, 1991
• Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
  Journal of Clinical Oncology, 1989
• Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1989
• The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.
  Journal of Clinical Oncology, 1989
• A randomized comparison of doxifluridine and fluorouracil in colorectal carcinoma
  European Journal of Cancer and Clinical Oncology, 1988
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958